In a recent statement, Adastra Labs confirmed that their amended license now permits them to “interact” with a maximum of 250 grams of cocaine and to import coca leaves to manufacture and synthesize the substance. CEO Michael Forbes emphasized that Adastra is committed to staying at the forefront of drug regulations and exploring innovative solutions to promote harm reduction.